|
Summary
September 2006, Vol. 3, No. 5, Pages 563-571
, DOI 10.1517/17425247.3.5.563
pH-responsive shielding of non-viral gene vectorsMartin Meyer1PhD Student, Pharmaceutical Biology–Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität, Butenandtstrasse 5-13, D-81377 Munich, Germany 2Professor and Chairman of Pharmaceutical Biology–Biotechnology, Pharmaceutical Biology–Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität, Butenandtstrasse 5-13, D-81377 Munich, Germany. ernst.wagner@cup.uni-muenchen.de PEG shielding of non-viral vectors reduces undesired interactions with the extracellular environment. Combination with cell-binding domains enables in vivo targeting via specific attachment to the target cells. Pegylation, however, also interferes with effective intracellular nucleic acid delivery. Consistently triggered removal of the PEG shield after reaching the target cell would make non-viral vectors more compatible with the intracellular delivery steps. Physiological triggers may include changes in pH, enzyme concentration or redox potential. This review focuses on pH-sensitive shielding strategies that exploit the endosomal acidification process after endocytosis for deshielding of the delivery system. Forward Links to Citing ArticlesErnst Wagner. (2007) Programmed drug delivery: nanosystems for tumor targeting. Expert Opinion on Biological Therapy 7:5, 587-593 Online publication date: 1-May-2007. Summary | Full Text | PDF (395 KB) | PDF Plus (391 KB) Users who read this article also read:
|
|





Author for correspondence
TOC Alert